Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

New England Compounding Is Probed by Justice Department

Oct. 16 (Bloomberg) -- New England Compounding Pharmacy Inc., which does business as New England Compounding Center, is being investigated by the U.S. Justice Department after an outbreak of fungal meningitis was linked to steroid shots it manufactured.

“This office and our law enforcement partners are investigating allegations concerning the New England Compounding Center,” U.S. Attorney Carmen Ortiz in Boston said yesterday in a statement. “It is entirely premature to suggest what the results of the investigation will be.”

The U.S. fungal meningitis outbreak that began with a steroid used for back pain has led to 233 infections, killing 16 people, the Centers for Disease Control and Prevention and the Virginia Department of Health said yesterday. Any drug meant to be injected that was manufactured by New England Compounding Center may be tainted, the Food and Drug Administration said Oct. 15 on its website.

Krista Robinson, an outside spokeswoman for Framingham, Massachusetts-based New England Compounding, didn’t immediately return a call for comment on the Justice Department’s statement after regular business hours yesterday.

To contact the reporter on this story: Edvard Pettersson in Los Angeles at

To contact the editor responsible for this story: Michael Hytha at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.